Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the In Vivo Toxicology Market Heading Into 2029?
The market for in-vivo toxicology has experienced significant growth in the past few years. It is projected to expand from $5.24 billion in 2024 to $5.61 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.1%. This historical growth can be attributed to various factors such as the increasing demand for studies that comply with Good Laboratory Practice (GLP), the broadening of reach regulations, an increase in biologics and biosimilars that require safety evaluations, more investment in the development of oncology drugs, and the proliferation of gene and cell therapy pipelines.
It is anticipated that the in-vivo toxicology market will experience robust growth in the forthcoming years, with the market value projected to reach $7.31 billion in 2029, registering a compound annual growth rate (CAGR) of 6.8%. This upward trend during the projection period can be associated with factors such as the escalating global activities in drug development, increasing demand for personalized healthcare, growth in clinical trials, the rise in toxicology testing outsourcing by pharmaceutical entities, and expanding consumer safety concerns in the food and personal care commodities sector. Key trend-shifts expected during the projection period encompass the creation of sophisticated animal models, the incorporation of imaging technologies into in-vivo studies, the advent of automated data gathering systems, the utilization of Artificial Intelligence (AI) and Machine Learning (ML) in analyzing toxicology data, and advancements in telemetry and biomarker identification in animals.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp
Which Factors Are Pushing The In Vivo Toxicology Market Forward?
The surge in drug discoveries is anticipated to fuel the expansion of the in vivo toxicology market. The process involves the scientific recognition and development of novel compounds that can potentially serve as remedies or prevention for various illnesses. The advancement in biotechnology has greatly improved this mechanism by improving comprehension of disease mechanisms and allowing for the creation of more specific therapies. An essential aspect of drug discovery, in vivo toxicology facilitates safety evaluation, tolerability and potential side effects of investigational compounds in entire organisms. It aids in identifying dose-limiting toxicities and contributes to formulating dosing plans before clinical development. For example, as per an article issued by the Government of Canada in May 2025, a Canada-based statutory body states that the number of medicines in clinical development globally reached 10,134 in March 2025, marking a 20% rise since September 2021. Thus, the escalating number of drug discoveries is propelling the growth of the in vivo toxicology market.
Which Segment Held The Largest Share In The In Vivo Toxicology Market In 2025?
The in vivo toxicology market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing
3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals
4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications
5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms
Subsegments:
1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents
2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems
How Are Key Trends Driving Expansion In The In Vivo Toxicology Industry?
Major firms involved in the in vivo toxicology sector are revamping their strategies to create state-of-the-art solutions, like secure, real-time data platforms based on the cloud, in order to enhance study administration and speed up decision-making processes. These secure and cloud-managed platforms provide real-time access to study related data, planning resources, milestones, and documents, securely and remotely to both researchers and clients, thereby improving transparency and cooperation. Charles River Laboratories International Inc., an American contract research organization, unveiled Apollo – a secure and cloud-based platform for real-time access to toxicology study data, in March 2023. Apollo is designed to support general toxicology studies in vivo with data visualization, planning, and milestone tracking tools, enabling real-time access to essential study data, and hence, facilitating faster and better-informed decisions. It also aids in streamlining budget estimation and project planning throughout the drug development process. Apollo’s digitalization of toxicology workflows enhances precision, efficiency, and partnership during in vivo research.
Which Organizations Are Driving Progress In The In Vivo Toxicology Industry?
Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, SGS Société Générale de Surveillance SA, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., SRI International, MatTek Corporation, Transcure Bioservices Pvt. Ltd., Altogen Labs.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report
Which Region Is Expected To Experience The Highest Growth In The In Vivo Toxicology Industry?
North America was the largest region in the in-vivo toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=25791&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
